489 related articles for article (PubMed ID: 21236582)
21. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
22. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment.
Kuo YR; Wu WS; Jeng SF; Wang FS; Huang HC; Lin CZ; Yang KD
Lasers Surg Med; 2005 Jan; 36(1):38-42. PubMed ID: 15662627
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
24. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
[TBL] [Abstract][Full Text] [Related]
25. [Change of gene expression of transforming growth factor-beta1, Smad 2 and Smad 3 in hypertrophic scars skins].
Chen W; Fu X; Sun T; Sun X; Zhao Z; Sheng Z
Zhonghua Wai Ke Za Zhi; 2002 Jan; 40(1):17-9. PubMed ID: 11955370
[TBL] [Abstract][Full Text] [Related]
26. Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid.
Kössi J; Vähä-Kreula M; Peltonen J; Risteli J; Laato M
Arch Dermatol Res; 2004 May; 295(12):521-6. PubMed ID: 15045512
[TBL] [Abstract][Full Text] [Related]
27. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
[TBL] [Abstract][Full Text] [Related]
28. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
30. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
[TBL] [Abstract][Full Text] [Related]
31. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of mRNA and protein of eIF4E, p-eIF4E and MCl-1 in pathological scar].
Wu WY; Zhang LT; Zheng ZF; Zhu SZ; Wang ZY
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 Sep; 28(5):360-5. PubMed ID: 23259313
[TBL] [Abstract][Full Text] [Related]
33. Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid.
Hsu YC; Chen MJ; Yu YM; Ko SY; Chang CC
Arch Dermatol Res; 2010 Dec; 302(10):717-24. PubMed ID: 20717830
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
[TBL] [Abstract][Full Text] [Related]
35. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
[TBL] [Abstract][Full Text] [Related]
36. Regulation of collagen gene expression in keloids and hypertrophic scars.
Friedman DW; Boyd CD; Mackenzie JW; Norton P; Olson RM; Deak SB
J Surg Res; 1993 Aug; 55(2):214-22. PubMed ID: 8412102
[TBL] [Abstract][Full Text] [Related]
37. Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen.
Kuroda K; Okamoto O; Shinkai H
J Invest Dermatol; 1999 May; 112(5):706-10. PubMed ID: 10233760
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
[TBL] [Abstract][Full Text] [Related]
39. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
Yamamoto T; Eckes B; Krieg T
Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980
[TBL] [Abstract][Full Text] [Related]
40. The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid.
Chen J; Zeng B; Yao H; Xu J
Burns; 2013 May; 39(3):465-72. PubMed ID: 22981800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
